RECRUITINGOBSERVATIONAL
The Hepatitis C Transplant Collaborative
Nationwide Hepatitis C NAT+ Cardiac Transplant Experience
About This Trial
In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.
Who May Be Eligible (Plain English)
Who May Qualify:
1. Recipient of a proven HCV NAT+ donor heart.
2. Re-transplant patients will be included.
Who Should NOT Join This Trial:
1\. Multi-organ transplantation
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
1. Recipient of a proven HCV NAT+ donor heart.
2. Re-transplant patients will be included.
Exclusion Criteria:
1\. Multi-organ transplantation
Locations (1)
Baylor Scott & White Health Research Institute
Dallas, Texas, United States